+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Droxidopa"

Orthostatic Hypotension Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Orthostatic Hypotension Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
Orthostatic Hypotension Drugs - Global Strategic Business Report - Product Thumbnail Image

Orthostatic Hypotension Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 286 Pages
  • Global
From
Orthostatic Hypotension Drugs Market 2024-2028 - Product Thumbnail Image

Orthostatic Hypotension Drugs Market 2024-2028

  • Report
  • December 2024
  • 172 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Droxidopa is a synthetic amino acid used to treat symptomatic neurogenic orthostatic hypotension (NOH) in adults. It is a cardiovascular drug that works by increasing the levels of norepinephrine, a neurotransmitter that helps regulate blood pressure. It is available in capsule form and is taken orally. Droxidopa is used to treat the symptoms of NOH, such as dizziness, lightheadedness, and fatigue. It is also used to improve quality of life in patients with NOH. It is not recommended for use in patients with severe hypertension or heart failure. The Droxidopa market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are involved in research and development, manufacturing, marketing, and distribution of the drug. They also provide support services such as patient education and counseling. Some companies in the Droxidopa market include Lundbeck, Jazz Pharmaceuticals, and Avanir Pharmaceuticals. Show Less Read more